Log in to save to my catalogue

Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis

Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6621547

Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis

About this item

Full title

Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2019-05, Vol.78 (5), p.676-682

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

ObjectivesOsteoarthritis (OA) is a painful and debilitating disease and it is associated with aberrant upregulation of multiple factors, including matrix metalloproteinase 13 (MMP13), interleukin-1β (IL-1β) and nerve growth factor (NGF). In this study, we aimed to use the CRISPR/Cas9 technology, a highly efficient gene-editing tool, to study whethe...

Alternative Titles

Full title

Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6621547

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6621547

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2018-214724

How to access this item